Assignee
HINOVA PHARMACEUTICALS INC
CN·12 granted patents·18 pending applications·4 citations·filing 2012–2024
Top patents by PatentIndex Score
30 records- 0176US9346764B2Imidazolidinedione compounds and their usesHINOVA PHARMACEUTICALS INC·Filed 2012·Granted May 24, 2016·3 cites·14 claims
- 0272US2025082763A1Combination drug for treating triple-negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0372US2025082764A1Drug for treating triple negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0468US11572371B2BRD4 inhibitorHINOVA PHARMACEUTICALS INC·Filed 2018·Granted Feb 7, 2023·1 cites·15 claims
- 0561US2019298696A1Deuterated imidazolidinedione compounds and their usesHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0661US2024269127A1Quinoline compound sustained-release tablet and preparation method thereforHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0760US11926618B2Halogen-substituted phenylate compound and applications thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Granted Mar 12, 2024·0 cites·11 claims
- 0860US2021137890A1Deuterated imidazolidinedione compounds and their usesHINOVA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0959US2026015341A1Pi3k inhibitor, preparation method therefor, and use thereofHINOVA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1057US12194040B2FAK inhibitor and drug combination thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Jan 14, 2025·0 cites·5 claims
- 1156US11891379B2Deuterated Defactinib compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 6, 2024·0 cites·12 claims
- 1254US2024383908A1Synthesis and application of phosphatase degraderHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1353US2025250254A1Deuterated heterocyclic ketone compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1453US2024277710A1Pharmaceutical composition for treatment of cancer and use thereofHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1552US12497392B2EP300/CBP inhibitorHINOVA PHARMACEUTICALS INC·Filed 2020·Granted Dec 16, 2025·0 cites·18 claims
- 1652US9708289B2Imidazole diketone compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2014·Granted Jul 18, 2017·0 cites·7 claims
- 1752US2025051347A1Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degraderHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1851US2021290553A1Hc-1119 formulation, preparation method and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1950US12162878B2BRD4 inhibitor as well as a preparative method and use thereofHINOVA PHARMACEUTICALS INC·Filed 2021·Granted Dec 10, 2024·0 cites·20 claims
- 2048US2024059678A1Synthesis Method for Aminopyrimidine FAK Inhibitor CompoundHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2144US11447477B2Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereofHINOVA PHARMACEUTICALS INC·Filed 2018·Granted Sep 20, 2022·0 cites·1 claims
- 2244US2021292304A1Deuterated mgl-3196 compound and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2343US2022177459A1Aromatic amine compound and use thereof in preparation of ar and brd4 dual inhibitors and regulatorsHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2442US11591301B2Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 2542US2023091225A1Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2642US2022087996A1Histone acetylase p300 inhibitor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2742US2022257774A1Aromatic amine ar ahd bet targeting protein degradation chimera compound and useHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2841US11753392B2Method for synthesis of deuterated amide and deuterated sulfonamideHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Sep 12, 2023·0 cites·26 claims
- 2936US10450274B2Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drugHINOVA PHARMACEUTICALS INC·Filed 2016·Granted Oct 22, 2019·0 cites·13 claims
- 3030US2020087261A1Method for preparing deuterated imidazole diketone compoundHINOVA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →